When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
PFNX - Ligand to buy Pfenex for up to $516M deal value
Pfenex Inc.
Ligand Pharmaceuticals (NASDAQ:LGND) has agreed to acquire Pfenex (NYSEMKT:PFNX) at $12/share, equivalent to $438M in equity value, representing a 57% premium to Pfenex’s last close price of $7.66 on August 10.
More news on: Ligand Pharmaceuticals Incorporated, Pfenex Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move,